Monday, February, 13, 2012

Testosterone Gel

Featured Article

The U.S. Food and Drug Administration (FDA) has announced that it is requiring manufacturers of two prescription topical testosterone gels, AndroGel and Testim, to include a boxed warning on the products’ labels. The FDA took this action after receiving reports of adverse effects in children who were inadvertently exposed to testosterone through contact with another person being treated with the products. Adverse events reported in these children included inappropriate enlargement of the...

Read more

More information on "Testosterone Gel"

From Our Experts

See more SharePosts »

From Our Sources

More on Menopause »